Bakhu Holdings, Corp.
BKUH
Other OTC0.00
USD
- -
- -
CIK
0001440153
ISIN
US0575862083
CUSIP
057586208
Return %
Stock
S&P500
1Y
-95.00
18.85
3Y
-99.90
64.56
5Y
-99.98
71.64
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- CEO
- Konstantia Galazi
- Full Time Employees
- 2
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Address
- One World Trade Center Long Beach CA United States of America 90831
- IPO Date
- Feb 13, 2018
- CIK
- 0001440153
- Website
- bakhuholdings.com
- Similar Companies
- Business
- Bakhu Holdings, Corp. focuses on the production, manufacturing, and sale of cannabis-related byproducts, primarily targeting medical, food additive, and recreational markets. The company specializes in cannabis plant cell-extraction and replication technologies and offers proprietary equipment, processes, and medium formulations designed to produce cannabinoids such as cannabidiol (CBD) and tetrahydrocannabinol (THC). Its applications span medical use, food additives, and recreational cannabis products across North America, Central America, and the Caribbean. Bakhu Holdings operates through strategic joint ventures, sublicensing, and partnerships to commercialize its cannabis technologies and products. Founded in 2008 and headquartered in Long Beach, California, Bakhu Holdings was formerly known as Planet Resources, Corp. until its name change in May 2009. The company has recently undergone a major corporate restructuring aimed at facilitating future financing opportunities, including a proposed $10 million private placement through secured notes. This restructuring involves the cancellation of preferred stock with supervoting rights and an agreement that allows new investors to appoint a majority of the board, pending shareholder approval. These changes are designed to support growth and expand the company's commercialization efforts for its proprietary cannabis technologies. Bakhu Holdings continues to enhance its product and service offerings by leveraging its patented cell-extraction and replication processes to target the growing cannabis market with cannabinoid-based products. It operates exclusively in the pharmaceutical and biotech sector focusing on cannabis-derived compounds, emphasizing innovation in cannabinoid production and commercialization strategies. Its ongoing strategic plans include expanding its market presence through joint ventures and licensing agreements to access a wider range of geographic markets throughout the Americas. The company remains in a development stage, actively pursuing funding and operational scaling to advance its product commercialization.